SYShin Yasui

Shin Yasui

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shin Yasui has a total of 149 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Liver cirrhosis is a risk factor for poor prognosis of acute cholangitis caused by choledocholithiasis

    by Miyuki Sensui, Shin Yasui, Sadahisa Ogasawara, Hidehiro Kamezaki, Motoyasu Kan, Shikiko Maruta, Toshihito Yamada, Yoshifumi Miura, Kosho Asano, Yukiko Shima, et al.


  • Open Access

    Long-term effects of endoscopic papillary large balloon dilation in patients with challenging bile duct calculi

    by Hidehiro Kamezaki, Terunao Iwanaga, Takahiro Maeda, Jun-Ichi Senoo, Dai Sakamoto, Shin Yasui, Harutoshi Sugiyama, Toshio Tsuyuguchi, Naoya Kato

    Endoscopic papillary large balloon dilation (EPLBD) can be used to treat challenging common bile duct stones. No previous studies have reported intractable cases treated either by EPLBD or mechanical lithotripter use. We aimed to evaluate and compare the long-term effects of EPLBD with mechanical lithotripter use. This retrospective cohort study reviewed data from 153 patients admitted to the Eastern Chiba Medical Center from April 2014 to March 2020, presenting with common bile duct calculi that could not be removed using a basket or balloon catheter. Patients were divided into groups depending on whether the treatment was performed using a mechanical lithotripter or EPLBD. The primary outcome was the recurrence rate of common bile duct calculi, and the secondary outcome was the rate of postoperative adverse events. The Wilcoxon test was used to compare the 2 groups. Statistical significance was set at P < .05. The median age of patients included in the lithotripter and EPLBD groups were 73 years and 83 years, respectively (P = .006), while the sex ratio (male:female) in the groups was 18:13 and 55:67, respectively. The EPLBD group showed a statistically larger median bile duct diameter (13 mm [range: 8–24 mm] vs 11 mm [range: 5–16 mm]; P < .001), larger maximal calculus diameter (median, 13.5 mm [range: 8–25 mm] vs 11 mm [range: 7–16 mm]; P < .001), and shorter median cumulative treatment time after reaching the duodenal papilla (35.5 minutes [range: 10–176 minutes] vs 47 minutes [range: 22–321 minutes]; P = .026) in comparison to the lithotripter group. There was no significant difference in the rate of adverse events between the EPLBD and the mechanical lithotripter groups. The recurrence rate was significantly lower (P = .014) in the EPLBD group. EPLBD increases therapeutic efficacy and reduces treatment duration for patients in whom calculus removal is difficult, without increasing the frequency of adverse events. No serious adverse events were observed. Additionally, EPLBD appears to reduce the risk of long-term recurrence. Future studies are needed to evaluate long-term outcomes in younger patients.


  • Analysis of circulating cell-free DNA after endoscopic ultrasound-guided fine needle aspiration in pancreatic ductal adenocarcinoma

    by Kosho Asano, Rintaro Mikata, Tetsuhiro Chiba, Motoyasu Kan, Shikiko Maruta, Toshihito Yamada, Yoshifumi Miura, Yukiko Shima, Miyuki Sensui, Hiroki Nagashima, et al.


  • Open Access

    Percutaneous Two-Dimensional Shear Wave Elastography for Diagnosis of Pancreatic Tumor

    by Yotaro Iino, Hitoshi Maruyama, Rintaro Mikata, Shin Yasui, Keisuke Koroki, Hiroki Nagashima, Masami Awatsu, Ayako Shingyoji, Yuko Kusakabe, Kazufumi Kobayashi, et al.

    Background: To investigate the efficacy of two-dimensional shear wave elastography (2D-SWE) for the diagnosis of pancreatic mass lesions. Methods: This ethics committee–approved cross-sectional study included 52 patients with histologically-proven pancreatic tumors (pancreatic ductal adenocarcinoma (PDAC), 36; tumor-forming pancreatitis (TFP), 15; neuroendocrine tumor, 1) and 33 control subjects. The 2D-SWE was performed for the tumor/non-tumor tissues, and SWE-mapping patterns and propagation quality were assessed. Results: Three mapping patterns were detected based on the size and distribution of the coloring areas. Pattern A (whole coloring) was detected in all non-tumor tissues and TFP, whereas pattern C (multiple small coloring spots) was detected in PDAC only. Pattern B (partial coloring with smaller spots) was detected in other lesions. The specificity and positive predictive value of pattern A for non-PDAC and those of pattern C for PDAC were 100%. The SWE value was higher in tumor lesions than in the non-tumor tissues (38.1 vs. 9.8 kPa; p < 0.001) in patients with PDAC. The SWE value in the non-tumor lesion was higher in patients with PDAC than in control (9.8 vs. 7.5 kPa; p < 0.001). Conclusions: 2D-SWE may play a role as a novel diagnostic tool for PDAC to detect a specific mapping pattern with quantitative assessment.


  • Open Access

    Practical guide on on-line hemodiafiltration for acute liver failure

    by Kazuaki Inoue, Shigeto Oda, Ryuzo Abe, Yasuhiro Takikawa, Nobuaki Nakayama, Naoya Kato, Keiichi Fujiwara, Shin Yasui, Shuji Terai, Akio Ido, et al.


  • Open Access

    Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients

    by Junichiro Kumagai, Takashi Taida, Sadahisa Ogasawara, Tomoo Nakagawa, Yotaro Iino, Ayako Shingyoji, Kentaro Ishikawa, Naoki Akizue, Mutsumi Yamato, Koji Takahashi, et al.

    In Western countries, most patients with primary sclerosing cholangitis (PSC) have concurrent ulcerative colitis (UC). The number of patients with UC in East Asia has increased markedly over the past two decades. However, current clinical features of PSC and of PSC associated with UC (PSC-UC) have not yet been clarified in East Asia, particularly in Japan. We aimed to reveal the clinical courses and associations with UC in Japanese patients with PSC from the mutual viewpoint of PSC and UC. We retrospectively retrieved medical records of patients with PSC (69) and UC (1242) who were diagnosed at Chiba University Hospital between June 1991 and August 2017. In the present cohort, 37 patients had PSC-UC; the cumulative risks of PSC in patients with UC and of UC in patients with PSC were 3.0% and 53.6%, respectively. We confirmed similar distinctive results by a Japanese nationwide survey, noting that younger patients with PSC had a notably high possibility of association with UC. From the viewpoint of the UC cohort, the occurrence of right-sided disease was significantly higher in patients with PSC-UC than in those with UC (16.2% vs. 4.2%, P = 0.003). Pancolitis was more commonly observed in PSC-UC, and proctits/left-sided colitis was less commonly found in patients with UC. The number of patients with young-onset PSC-UC may be increasing similar to an increase in patients with UC in Japan. In our cohort, the comorbidity rate of PSC-UC was higher than that obtained in previous reports. The incidence of PSC-UC and UC may increase in the future in East Asia, particularly in Japan.


  • Usefulness of the 2-Devices-in-1-Channel Method in Case of Difficult Selective Biliary Cannulation Due to Parapapillary Diverticulum/Diverticular Papilla

    by Yuji Sakai, Toshio Tsuyuguchi, Harutoshi Sugiyama, Rintaro Mikata, Hiroshi Ohyama, Shin Yasui, Masato Nakamura, Koji Takahashi, Junichjiro Kumagai, Mutsumi Yamato, et al.

    Purpose: To investigate whether the 2-devices-in-1-channel method is useful for selective biliary cannulation in patients with parapapillary diverticulum or intradiverticular papilla, where the papilla cannot be seen from the front. Materials and Methods: Biliary cannulation using the 2-devices-in-1-channel method was performed in 28 patients who presented difficulty due to parapapillary diverticulum or intradiverticular papilla. There were 15 men and 13 women whose mean age was 68.8 (58 to 88) years. There were 22 patients with common bile duct stones, 5 with pancreatic cancer, and 1 with gallbladder cancer. Results: Selective biliary cannulation was successful in all 28 patients. Common bile duct stones could be removed in all 22 patients after endoscopic sphincterotomy or endoscopic balloon dilation, and all 5 patients with pancreatic cancer as well as the patient with gallbladder cancer were successfully drained. There were no procedure-related complications. Conclusions: From these results, we consider the 2-devices-in-1-channel method is useful and safe to perform selective biliary cannulation when the papilla cannot be seen from the front due to parapapillary diverticulum, or intradiverticular papilla.


  • Characteristics and clinical outcomes of endoscopic transpapillary gallbladder drainage

    by Koji Takahashi, Toshio Tsuyuguchi, Harutoshi Sugiyama, Junichiro Kumagai, Masato Nakamura, Yotaro Iino, Ayako Shingyoji, Mutsumi Yamato, Hiroshi Ohyama, Yuko Kusakabe, et al.

    【目的】急性胆囊疾患に対する内視鏡的経乳頭的胆囊ドレナージ術の治療成績を分析し,その特徴を明らかにすること.【対象と方法】2012年1月から2017年10月までの期間において,治療目的で内視鏡的経乳頭的胆囊ドレナージ術を試みた25例を後方視的に調査した.【結果】治療対象とした急性胆囊疾患の内訳は,急性胆囊炎が22例(88%),胆囊出血2例(8%),胆囊穿孔1例(4%)であった.技術的成功率は76%(19/25例)で,内視鏡的経乳頭的胆囊ステント留置術を13例,内視鏡的経鼻胆囊ドレナージ術を6例に行っていた.技術的成功例の中での臨床的成功率は,84%(16/19例)であった.臨床的不成功となったのは,胆囊出血に対して内視鏡的経鼻胆囊ドレナージ術を行った2例と,軽症急性胆囊炎に対する内視鏡的経乳頭的胆囊ステント留置術後に遅発性胆囊穿孔が起きた1例であり,これら3例は外科手術となった.偶発症は2例(8%)で起こり,胆囊管穿孔1例と遅発性胆囊穿孔1例であった.【考察】検討対象となった全25例において,内視鏡的経乳頭的胆囊ドレナージ術は16例(64%)の症例に有効であった.経乳頭的胆囊ドレナージ術は,経皮経肝胆囊ドレナージ術が適さない胆囊炎で,胆囊出血がない場合に治療選択肢の1つとなると考えられた.

  • An adult case of primary biliary cholangitis accompanied by a patent ductus venosus showing type-I congenital absence of the portal vein

    by Soichiro Kiyono, Hitoshi Maruyama, Kazufumi Kobayashi, Taro Shimada, Masanori Takahashi, Masato Nakamura, Shingo Nakamoto, Shin Yasui, Tatsuo Kanda, Tomoko Saito, et al.

    症例は40歳,男性.慢性腎不全による腎移植後のため,近医で通院加療を受けていた.高アンモニア血症と意識消失発作を認め,同院のCT検査で腹部血行異常を疑われたため精査目的に紹介となった.超音波では,門脈から下大静脈へ連続する管腔構造が認められ,門脈側から下大静脈へ向かう血流が観察されたことから静脈管開存が疑われた.血管造影検査では下大静脈から短絡路部へバルンカテーテルが挿入され,静脈管開存の存在が確認された.バルンカテーテルによる短絡路の閉塞試験では,門脈ならびに脾静脈血流は停滞し肝内門脈血流も観察されなかった.以上より,先天性門脈欠損症I型と診断され,外科的な短絡路結紮切離による改善は期待できないと考えられた.なお肝生検組織から,原発性胆汁性胆管炎(Scheuer分類Stage 2,中沼分類Stage 3)と診断された.今後,肝移植の適応を含めた診療の展開が求められる.

  • Open Access

    Successful retreatment with sofosbuvir plus ledipasvir for cirrhotic patients with hepatitis C virus genotype 1b, who discontinued the prior treatment with asunaprevir plus daclatasvir: A case series and review of the literature

    by Yuki Haga, Tatsuo Kanda, Shin Yasui, Masato Nakamura, Yoshihiko Ooka, Koji Takahashi, Shuang Wu, Shingo Nakamoto, Makoto Arai, Tetsuhiro Chiba, et al.

    Https://doi.org/10.18632/oncotarget.24620 Tatsuo Kanda, Shin Yasui, Masato Nakamura, Shingo Nakamoto, Koji Takahashi, Shuang Wu, Reina Sasaki, Yuki Haga, Sadahisa Ogasawara, Tomoko Saito, Kazufumi...